Syrona Women company
%20.jpg)
Syrona Women develops a non-invasive cancer screening kit designed to facilitate early stage detection of gynecological cancers at home. The company's kit combines an automated diagnostic technology and a unique sample that enables detection of multiple novel biomarkers indicative of STIs and reproductive cancers, STDs and gynecological cancers so as to let women screen and manage their own reproductive health at homes, enabling women to keep a check of their gynecological health by themselves without having to wait for time-consuming diagnostics in clinics.
Founded Date:
2018-01-01
Total Funding:
$678.9K
Investor Type:
For Profit
Employee Number:
1-10
Funding Status:
Seed
Technology:
Longevity FemTech
Last Funding Type:
Grant
Investors Number:
2
Industry:
Health Care
Headquarters:
London, England, United Kingdom
Estimated Revenue:
Less than $1M